Get startedLog in
    Picture of JW (Cayman) Therapeutics Co logo

    2126 — JW (Cayman) Therapeutics Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Jw Therapeutics Announces IND Approval For Trial Of Relma-Cel In Autoimmune Disease Patients

    Picture of JW (Cayman) Therapeutics Co logoJW (Cayman) Therapeutics Co
    10/04/2023 13:15
    April 10 (Reuters) - JW (Cayman) Therapeutics Co Ltd
 2126.HK :
    * JW THERAPEUTICS ANNOUNCES IND APPROVAL FOR THE CLINICAL
TRIAL OF
RELMA-CEL IN PATIENTS WITH MODERATELY OR SEVERELY REFRACTORY
SYSTEMIC LUPUS ERYTHEMATOSUS

Source text for Eikon:  ID:nPn9HyQ7Pa 
Further company coverage:  2126.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on JW (Cayman) Therapeutics Co

    See all news